HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.

AbstractSETTING:
Three centres for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Istanbul, Turkey: Heybeliada Centre for Chest Diseases and Thoracic Surgery, Süreyyapaşa Centre for Chest Diseases and Thoracic Surgery and Yedikule Centre for Chest Diseases and Thoracic Surgery.
OBJECTIVE:
To evaluate the presence of ethionamide (ETH) resistance and its effect on time to sputum smear negativity in MDR-TB patients who had not previously received second-line anti-tuberculosis drugs.
DESIGN:
Drug susceptibility testing for isoniazid (INH), rifampicin (RMP), ethambutol, streptomycin and ETH was performed on 50 patients treated between August 2004 and May 2005. Indirect agar proportion and BACTEC methods were used to determine ETH susceptibility.
RESULTS:
Of the patients who were resistant to at least INH and RMP, 11 (22%) (three [27.3%] new and eight [72.7%] retreatment) were resistant to ETH with the BACTEC method. Of 18 new patients, three (16.6%) were ETH-resistant using the BACTEC method compared to 8/32 (25%) retreatment patients. The mean time to smear negativity was 75.2 days in ETH-resistant patients and 50 days in susceptible patients (P < 0.05). Both ETH-resistant and -susceptible groups were homogeneous for factors that may have a possible effect on time to conversion.
CONCLUSION:
Not only ETH resistance but also age and radiologically advanced disease adversely affected time to sputum conversion.
AuthorsNurcin O Cimen, Z Arslan, A Saygi, K Ocak, F Babacan, M Kurutepe
JournalThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease (Int J Tuberc Lung Dis) Vol. 13 Issue 7 Pg. 907-13 (Jul 2009) ISSN: 1027-3719 [Print] France
PMID19555543 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antitubercular Agents
  • Ethambutol
  • Agar
  • Ethionamide
  • Isoniazid
  • Rifampin
  • Streptomycin
Topics
  • Adolescent
  • Adult
  • Agar
  • Antitubercular Agents (pharmacology, therapeutic use)
  • Chi-Square Distribution
  • Child
  • Ethambutol (pharmacology, therapeutic use)
  • Ethionamide (pharmacology, therapeutic use)
  • Humans
  • Isoniazid (pharmacology, therapeutic use)
  • Microbial Sensitivity Tests
  • Middle Aged
  • Prospective Studies
  • Radiometry (methods)
  • Regression Analysis
  • Rifampin (pharmacology, therapeutic use)
  • Sputum (microbiology)
  • Streptomycin (pharmacology, therapeutic use)
  • Tuberculosis, Multidrug-Resistant (drug therapy, epidemiology)
  • Turkey (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: